105 related articles for article (PubMed ID: 31358091)
1. Glucose Transporter 1 Overexpression in Oral Squamous Cell Carcinoma.
Qamar S; Fatima S; Rehman A; Khokhar MA; Mustafa Z; Awan N
J Coll Physicians Surg Pak; 2019 Aug; 29(8):724-727. PubMed ID: 31358091
[TBL] [Abstract][Full Text] [Related]
2. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
Tian M; Zhang H; Nakasone Y; Mogi K; Endo K
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.
Oliver RJ; Woodwards RT; Sloan P; Thakker NS; Stratford IJ; Airley RE
Eur J Cancer; 2004 Mar; 40(4):503-7. PubMed ID: 14962715
[TBL] [Abstract][Full Text] [Related]
4. [A preliminary study on the relationship between GLUT-1,MCT-4 and CAⅨ in laryngeal squamous cell carcinoma].
Wang YB; Xu O; Zhang RJ; Shan CG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):510-514;519. PubMed ID: 29871299
[No Abstract] [Full Text] [Related]
5. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
Abdou AG; Eldien MM; Elsakka D
Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Pereira KM; Feitosa SG; Lima AT; Luna EC; Cavalcante RB; de Lima KC; Chaves FN; Costa FW
Asian Pac J Cancer Prev; 2016; 17(1):147-51. PubMed ID: 26838200
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S
J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of p53 Expression Intensity in Urothelial Cancers.
Qamar S; Inam QA; Ashraf S; Khan MS; Khokhar MA; Awan N
J Coll Physicians Surg Pak; 2017 Apr; 27(4):232-236. PubMed ID: 28492153
[TBL] [Abstract][Full Text] [Related]
10. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
Li SJ; Guo W; Ren GX; Huang G; Chen T; Song SL
Br J Oral Maxillofac Surg; 2008 Apr; 46(3):180-186. PubMed ID: 18093707
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis.
Li CX; Sun JL; Gong ZC; Lin ZQ; Liu H
Medicine (Baltimore); 2016 Nov; 95(45):e5324. PubMed ID: 27828852
[TBL] [Abstract][Full Text] [Related]
12. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.
Weiner MF; Miranda RN; Bardales RH; Mukunyadzi P; Baker SJ; Korourian S; De Las Casas LE
Diagn Cytopathol; 2004 Nov; 31(5):294-9. PubMed ID: 15468132
[TBL] [Abstract][Full Text] [Related]
14. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
[TBL] [Abstract][Full Text] [Related]
15. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma.
Grimm M; Munz A; Teriete P; Nadtotschi T; Reinert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):743-53. PubMed ID: 24703406
[TBL] [Abstract][Full Text] [Related]
16. The utility of GLUT-1 immunolocalization in cell blocks: An adjunct to the fine needle aspiration diagnosis of cystic squamous lesions of the head and neck.
Chandan VS; Faquin WC; Wilbur DC; Khurana KK
Cancer; 2006 Apr; 108(2):124-8. PubMed ID: 16435376
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
Kunkel M; Reichert TE; Benz P; Lehr HA; Jeong JH; Wieand S; Bartenstein P; Wagner W; Whiteside TL
Cancer; 2003 Feb; 97(4):1015-24. PubMed ID: 12569601
[TBL] [Abstract][Full Text] [Related]
18. Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study.
Panda A; Bandyopadhyay A; Mohiddin G; Raghuvanshi M; Sahoo SK; Bhuyan L
Niger J Surg; 2019; 25(2):203-207. PubMed ID: 31579378
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of glucose transporter-1 expression in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Patlolla P; N Shyam NDV; Kumar GK; Narayen V; Konda P; Mudududla P
J Oral Maxillofac Pathol; 2020; 24(3):578. PubMed ID: 33967505
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 Overexpression with Hormone Receptor Status and Triple Negative Breast Carcinoma.
Qamar S; Khokhar MA; Farooq S; Ashraf S; Humayon WA; Rehman A
J Coll Physicians Surg Pak; 2019 Feb; 29(2):164-167. PubMed ID: 30700357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]